Apyx Medical Corp Stock Nasdaq
Equities
US03837C1062
Medical Equipment, Supplies & Distribution
Sales 2024 * | 49.94M 68.29M | Sales 2025 * | 54.52M 74.56M | Capitalization | 48.5M 66.33M |
---|---|---|---|---|---|
Net income 2024 * | -27M -36.92M | Net income 2025 * | -25M -34.19M | EV / Sales 2024 * | 0.97 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.89 x |
P/E ratio 2024 * |
-1.79
x | P/E ratio 2025 * |
-2.01
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.08% |
Latest transcript on Apyx Medical Corp
Managers | Title | Age | Since |
---|---|---|---|
Charles Goodwin
CEO | Chief Executive Officer | 58 | 17-12-14 |
Andrew Makrides
FOU | Founder | 82 | 77-12-31 |
Matthew Hill
DFI | Director of Finance/CFO | 56 | 12-03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Andrew Makrides
FOU | Founder | 82 | 77-12-31 |
Lawrence Waldman
BRD | Director/Board Member | 77 | 11-03-14 |
Craig Swandal
BRD | Director/Board Member | 63 | 18-03-08 |
1st Jan change | Capi. | |
---|---|---|
-2.54% | 186B | |
-1.85% | 107B | |
-4.26% | 67.44B | |
+1.39% | 50.03B | |
+16.82% | 47.81B | |
+4.79% | 41.03B | |
+3.49% | 26.85B | |
+0.65% | 25.82B | |
+16.55% | 24.74B |